Anti-heparan sulphate antibodies and homocysteine in dementia: Markers of vascular pathology?

Chiara Briani, Annachiara Cagnin, Livia Gallo, Elisabetta Toffanin, Mariacristina Varagnolo, Martina Zaninotto, Mario Plebani, Gianluigi Ricchieri, Leontino Battistin, Gilberto Pizzolato

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Increasing evidence supports a pathogenic role of heparan sulphate (HS) in the development of dementia. Since HS proteoglycans are present in the endothelial cells and perivascular basement membrane, we wanted to assess blood titres of HS antibodies (Abs) in patients with vascular dementia (VD) and in patients with Alzheimer's disease (AD) with cerebrovascular disease (CVD) [mixed dementia (MixD)]. Moreover, plasma levels of homocysteine, an independent risk factor for the development of dementia as well as for CVD, were also determined. High HS Abs titres were present in one patient with VD and in two patients with mixed dementia, as well as in two neurological control patients (stroke and epilepsy). Increased homocysteine levels were found in 62.5% of patients with mixed dementia, in 22.2% of the VD subjects, in 54.2% of patients with CVD, and in 41.2% of patients with other neurological diseases. The present findings suggest that neither elevated HS Abs titres nor increased homocysteinemia may represent a useful biochemical marker for the diagnosis of VD.

Original languageEnglish
Pages (from-to)215-218
Number of pages4
JournalJournal of the Neurological Sciences
Volume229-230
DOIs
Publication statusPublished - Mar 15 2005

Fingerprint

Vascular Dementia
Heparitin Sulfate
Homocysteine
Pathology
Antibodies
Dementia
Cerebrovascular Disorders
Heparan Sulfate Proteoglycans
Basement Membrane
Epilepsy
Alzheimer Disease
Endothelial Cells
Biomarkers
Stroke

Keywords

  • Heparan sulphate
  • Homocysteine
  • Vascular dementia

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Surgery
  • Neuroscience(all)
  • Developmental Neuroscience
  • Neurology

Cite this

Briani, C., Cagnin, A., Gallo, L., Toffanin, E., Varagnolo, M., Zaninotto, M., ... Pizzolato, G. (2005). Anti-heparan sulphate antibodies and homocysteine in dementia: Markers of vascular pathology? Journal of the Neurological Sciences, 229-230, 215-218. https://doi.org/10.1016/j.jns.2004.11.031

Anti-heparan sulphate antibodies and homocysteine in dementia : Markers of vascular pathology? / Briani, Chiara; Cagnin, Annachiara; Gallo, Livia; Toffanin, Elisabetta; Varagnolo, Mariacristina; Zaninotto, Martina; Plebani, Mario; Ricchieri, Gianluigi; Battistin, Leontino; Pizzolato, Gilberto.

In: Journal of the Neurological Sciences, Vol. 229-230, 15.03.2005, p. 215-218.

Research output: Contribution to journalArticle

Briani, C, Cagnin, A, Gallo, L, Toffanin, E, Varagnolo, M, Zaninotto, M, Plebani, M, Ricchieri, G, Battistin, L & Pizzolato, G 2005, 'Anti-heparan sulphate antibodies and homocysteine in dementia: Markers of vascular pathology?', Journal of the Neurological Sciences, vol. 229-230, pp. 215-218. https://doi.org/10.1016/j.jns.2004.11.031
Briani, Chiara ; Cagnin, Annachiara ; Gallo, Livia ; Toffanin, Elisabetta ; Varagnolo, Mariacristina ; Zaninotto, Martina ; Plebani, Mario ; Ricchieri, Gianluigi ; Battistin, Leontino ; Pizzolato, Gilberto. / Anti-heparan sulphate antibodies and homocysteine in dementia : Markers of vascular pathology?. In: Journal of the Neurological Sciences. 2005 ; Vol. 229-230. pp. 215-218.
@article{ced0b8ca34574a09b865d5d1d6a9c151,
title = "Anti-heparan sulphate antibodies and homocysteine in dementia: Markers of vascular pathology?",
abstract = "Increasing evidence supports a pathogenic role of heparan sulphate (HS) in the development of dementia. Since HS proteoglycans are present in the endothelial cells and perivascular basement membrane, we wanted to assess blood titres of HS antibodies (Abs) in patients with vascular dementia (VD) and in patients with Alzheimer's disease (AD) with cerebrovascular disease (CVD) [mixed dementia (MixD)]. Moreover, plasma levels of homocysteine, an independent risk factor for the development of dementia as well as for CVD, were also determined. High HS Abs titres were present in one patient with VD and in two patients with mixed dementia, as well as in two neurological control patients (stroke and epilepsy). Increased homocysteine levels were found in 62.5{\%} of patients with mixed dementia, in 22.2{\%} of the VD subjects, in 54.2{\%} of patients with CVD, and in 41.2{\%} of patients with other neurological diseases. The present findings suggest that neither elevated HS Abs titres nor increased homocysteinemia may represent a useful biochemical marker for the diagnosis of VD.",
keywords = "Heparan sulphate, Homocysteine, Vascular dementia",
author = "Chiara Briani and Annachiara Cagnin and Livia Gallo and Elisabetta Toffanin and Mariacristina Varagnolo and Martina Zaninotto and Mario Plebani and Gianluigi Ricchieri and Leontino Battistin and Gilberto Pizzolato",
year = "2005",
month = "3",
day = "15",
doi = "10.1016/j.jns.2004.11.031",
language = "English",
volume = "229-230",
pages = "215--218",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Anti-heparan sulphate antibodies and homocysteine in dementia

T2 - Markers of vascular pathology?

AU - Briani, Chiara

AU - Cagnin, Annachiara

AU - Gallo, Livia

AU - Toffanin, Elisabetta

AU - Varagnolo, Mariacristina

AU - Zaninotto, Martina

AU - Plebani, Mario

AU - Ricchieri, Gianluigi

AU - Battistin, Leontino

AU - Pizzolato, Gilberto

PY - 2005/3/15

Y1 - 2005/3/15

N2 - Increasing evidence supports a pathogenic role of heparan sulphate (HS) in the development of dementia. Since HS proteoglycans are present in the endothelial cells and perivascular basement membrane, we wanted to assess blood titres of HS antibodies (Abs) in patients with vascular dementia (VD) and in patients with Alzheimer's disease (AD) with cerebrovascular disease (CVD) [mixed dementia (MixD)]. Moreover, plasma levels of homocysteine, an independent risk factor for the development of dementia as well as for CVD, were also determined. High HS Abs titres were present in one patient with VD and in two patients with mixed dementia, as well as in two neurological control patients (stroke and epilepsy). Increased homocysteine levels were found in 62.5% of patients with mixed dementia, in 22.2% of the VD subjects, in 54.2% of patients with CVD, and in 41.2% of patients with other neurological diseases. The present findings suggest that neither elevated HS Abs titres nor increased homocysteinemia may represent a useful biochemical marker for the diagnosis of VD.

AB - Increasing evidence supports a pathogenic role of heparan sulphate (HS) in the development of dementia. Since HS proteoglycans are present in the endothelial cells and perivascular basement membrane, we wanted to assess blood titres of HS antibodies (Abs) in patients with vascular dementia (VD) and in patients with Alzheimer's disease (AD) with cerebrovascular disease (CVD) [mixed dementia (MixD)]. Moreover, plasma levels of homocysteine, an independent risk factor for the development of dementia as well as for CVD, were also determined. High HS Abs titres were present in one patient with VD and in two patients with mixed dementia, as well as in two neurological control patients (stroke and epilepsy). Increased homocysteine levels were found in 62.5% of patients with mixed dementia, in 22.2% of the VD subjects, in 54.2% of patients with CVD, and in 41.2% of patients with other neurological diseases. The present findings suggest that neither elevated HS Abs titres nor increased homocysteinemia may represent a useful biochemical marker for the diagnosis of VD.

KW - Heparan sulphate

KW - Homocysteine

KW - Vascular dementia

UR - http://www.scopus.com/inward/record.url?scp=20044377033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044377033&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2004.11.031

DO - 10.1016/j.jns.2004.11.031

M3 - Article

C2 - 15760642

AN - SCOPUS:20044377033

VL - 229-230

SP - 215

EP - 218

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

ER -